IL6 and COVID-19: Our results indicated that the highest IL-6 mRNA levels were not in the severe but mild inflamed tissue, implying that early treatment with glucocorticoids and IL-6 antagonists for mild inflammation could be beneficial against COVID-19; however, the treatment is not useful once activated macrophages cause the IL-6-induced cytokine storm.